Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors
- Didier Meulendijks
- , Ulrik N Lassen
- , Lillian L Siu
- , Alwin D R Huitema
- , Vaios Karanikas
- , Morten Mau-Sorensen
- , Derek J Jonker
- , Aaron R Hansen
- , Mary E Simcox
- , Kathleen J Schostack
- , Dean Bottino
- , Hua Zhong
- , Markus Roessler
- , Suzana M Vega-Harring
- , Tiantom Jarutat
- , David Geho
- , Karen Wang
- , Mark DeMario
- , Glenwood D Goss
- , Jan H M Schellens
21
Citations
(Scopus)